Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Buprenorphine-naloxone Treatment During the Perinatal Period: Fetal and Infant Effects

NCT03291847 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03291847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03291847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Buprenorphine-naloxone Treatment During the Perinatal Period: Fetal and Infant Effects
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2018
Completion date
December 15, 2023
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

maternal opioid use disorder, opioid exposed infant